I'm getting bombarded with "Reply from XXX" messages, so

New Post Public Reply Private Reply Replies (2) Message Board
homerbedloe balleroni #30996
380
I'm getting bombarded with "Reply from XXX" messages, so here's my thoughts:

Balleroni, I certainly respect your opinions but disagree with them (much as with Hylander's). Here's why:

Joe is not GNBT: I believe he is - without Joe, GNBT was a bankrupt company that I was writing off as losses against other gains. Joe gathered the talent of the folks running NGIO, Excellagen, and all the other initiatives, including stock splits and dividends. While taking longer than we hoped, Joe is solely responsible for GNBT even having those future potential revenue streams. And since so far, no one of his management picks has bolted from his vision, I've got to believe they continue to be viable with potential to be successes in the future.

$5k for a PR is ok if it boosts pps: But they haven't, and those are PRs with good news. Like getting payment from China, getting a positive response from the FDA on the pre-IND, getting the GMP certification, getting big names committed to produce the vaccine, etc. Do you really think a PR that states 'we're delayed because of X,Y or Z' will boost the pps when other PRs don't? I don't think so - in fact, I would expect the pps to further go down on the "we're delayed" portion of the PR.

Dilution is not being used wisely: Joe has pasted this together with string, duct tape and spit. How else is he going to make this a going concern without dilution? Covid probably delayed any shot at revenues for at least a year; but he had to keep the company open. Raising money through stock sales is about the only option available.

And on that same note, we're still only at 120 million shares (+ or -). That is not horrible compared to many other biotechs that are raising money through share sales. I credit Joe with judiciously selling shares based on what he needs at the time, not looking too far ahead. And that also signals to me Joe still believes there are revenues in the near future, which also helps keeping the dilution to a minimum.

Hylander - I understand your frustration with "communication", but if Joe has nothing to share that furthers the process, why share it when it costs the company 20,000 shares of stock dilution? My point is if you have no faith that Joe is doing anything "behind the scenes" other than sitting around not communicating, then it's probably in your best interest to no longer be an investor. I believe Joe is doing everything he can control behind the scenes, so I remain positive about the prospects of the company - that is what makes a market. But in my mind, spending money to say "we're waiting on the FDA" or "China hasn't paid us this amount yet, but we are sure they are going to" isn't fiscally responsible right now. Both messages have little chance of increasing pps, and as I mentioned above, I think they might even do further damage.

So I'm ok with waiting, because I think Joe is still working hard to advance both the IND submission and the IPO. It appears to me you don't. I'm not telling you to sell, I'm just asking, with those beliefs in the CEO of the company, why are you still invested?

Just my thoughts/opinions. Hopefully for you guys, this time I really will stay away.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Teva’s R&D Exit Puts Disclosure Questions in Focus

Updated Category News Views 68

An abrupt departure in the drug business is never just an HR memo. Teva Pharmaceutical Industries shares reportedly dropped about 8.74% after Eric Hughes, the company’s executive vice president of Global R&D and chief medical officer, left effective immediately. That kind of move rattles investors because R&D leadership is not decorative furniture at a pharmaceutical...

Continue Reading
Flair's New Aviation Alliance Offers Options, Not Orders

Updated Category News Views 55

Aircraft shortages have a funny way of turning vague partnerships into very useful insurance policies. Flair Airlines, Phoenix Aviation Capital and Avia Solutions Group announced a Strategic Commercial Cooperation Agreement on Nov. 19, 2026, and the sensible reading is straightforward: the Canadian value carrier wants more ways to solve capacity and operational problems...

Continue Reading
ASU's International Enrollment Lead Carries Real Weight

Updated Category News Views 90

Twenty thousand nine hundred twenty-six international students is not a campus footnote; it is a serious operating force moving through Arizona State University and the state around it. ASU has held the No. 1 spot among U.S. public universities hosting international students for six straight years, and the 2026 Open Doors report puts it No. 2 across public and private...

Continue Reading
Mars Sets $2 Billion Debt Tender With Kellanova Notes

Updated Category News Views 78

A two-billion-dollar vacuum cleaner just switched on inside Mars’s debt stack, and the timing is anything but casual. On November 20, Mars fixed the pricing for cash tender offers spanning selected Mars and Kellanova senior notes, with holders facing a 5:00 p.m. New York deadline that same day. This is the kind of filing that looks like bond-market plumbing until you...

Continue Reading
California Rideshare Data Exposes an Insurance Gap

Updated Category News Views 8

Three California counties carried an outsized share of rideshare traffic, and the insurance fine print is where this story gets uncomfortable. A review by Mendez & Sanchez says Los Angeles, San Francisco, and San Diego counties accounted for nearly two-thirds of statewide rideshare trips between September 2019 and August 2020. That is an old snapshot, sure, but it points...

Continue Reading
Simmons Clarifies Texas Loan Exposure, But Risks Remain

Updated Category News Views 87

A $45 million discrepancy is not a rounding error, and Simmons First National has every reason to swat it down hard. The bank says recent reporting overstated financing tied to a Texas multifamily development at $133 million. Its stated total is roughly $88 million, with about $44 million participated to another financial institution. For shareholders in NASDAQ:SFNC, that...

Continue Reading
BON’s Oat Lab Bet Puts Scale and Standards in Focus

Updated Category News Views 12

Oats Meet the Industrialization Problem Oats rarely make a small-cap story more interesting, yet this one has a real business nerve running through it. Bon Natural Life has teamed with China Oat Group to establish a joint laboratory aimed at biomanufacturing high-value, oat-derived natural ingredients. The headline is not simply another research collaboration. The stated...

Continue Reading
CITGO Sign Return Caps Kenmore's Careful Rebuild Work

Updated Category News Views 62

Thirty feet upward and 120 feet eastward is not the sort of move that usually stops a city in its tracks, yet Boston’s CITGO Sign was never merely rooftop hardware. Its public relighting in Kenmore Square marks the final phase of the redevelopment at 660 Beacon Street, and the real accomplishment is less flashy than the lights: a beloved, federally landmarked object...

Continue Reading
TOP-REAL Tests Digital Monitoring in HER2 Cancer Care

Updated Category News Views 133

A cancer treatment can be extraordinarily potent and still get derailed by what happens on an ordinary Tuesday at home. That unglamorous gap between clinic visits is the whole point of TOP-REAL, a phase II academic study presented at ESMO AI & Digital Oncology 2026. Solti and its European partners are testing whether closer digital follow-up can catch trouble early enough...

Continue Reading
Hoymiles Brings Plug-In Solar Flexibility to RE+ 2026

Updated Category News Views 70

A 1.8-kilogram box may not sound like much, but it captures where household solar is trying to go: smaller, less intimidating, and far easier to put to work. At RE+ 2026 in Las Vegas, Hoymiles laid out a residential lineup spanning plug-in solar, battery storage and conventional rooftop microinverters. This was not one flashy gadget looking for applause. It was a fairly...

Continue Reading

Top 5 Most Recently Viewed Articles

JPMorgan's Jamie Dimon Advocates for Office Work Among Feds

Updated Category News Views 130

JPMorgan's Jamie Dimon Advocates for Federal Employees to Return Jamie Dimon, the CEO of JPMorgan Chase, recently expressed his concerns about the numerous vacant offices in Washington, DC, calling on federal employees to head back to their workplaces. His statements have sparked a lively conversation about remote work and its effects on productivity as well as the...

Continue Reading
South Bow’s Robust Q3 2025 Performance and Future Plans

Updated Category News Views 270

South Bow's Third-Quarter Results & 2026 Projections CALGARY, Alberta, Nov. 13, 2025 -- South Bow Corp. (TSX: SOBO & NYSE: SOBO) has disclosed its financial and operational results for the third quarter of 2025 while providing insights about its outlook for 2026. All figures are presented in U.S. dollars unless noted otherwise. Performance Highlights Operational and...

Continue Reading
Smart Logistics Global Limited Completes Successful IPO Funding

Updated Category News Views 174

Smart Logistics Global Limited Successfully Closes IPO Smart Logistics Global Limited (NASDAQ: SLGB), a distinguished logistics solution provider based in Hong Kong, has recently announced the successful completion of its initial public offering (IPO). Through this offering of 1,000,000 ordinary shares priced at $5.00 each, the company generated a total of $5,000,000,...

Continue Reading
Mobilizing Capital to Achieve Sustainability Goals with UN

Updated Category News Views 196

Mobilizing Capital to Achieve Sustainability Goals with UN The UN Global Compact recently hosted a significant forum where over 50 CEOs and representatives convened to strategize on mobilizing private capital for sustainable and inclusive growth. With leaders from various sectors, the forum emphasized how collaboration between the business community and governmental...

Continue Reading
HASA Inc.'s Strategic Acquisition of Bio-Dex Labs

Updated Category News Views 27

Diving into the Pool Chemical Business What a splash in the world of pool chemicals! HASA Inc., the big kahuna in water treatment solutions, just scooped up Bio-Dex Laboratories, a name known far and wide among pool service pros. We're talking a serious step-up in HASA's game, as they integrate this trusted brand's top-notch products into their already hefty lineup. A...

Continue Reading